半导体激光治疗仪局部照射配合康复新液纱条外敷对肛肠术后创面促愈作用的临床研究.pdf

《半导体激光治疗仪局部照射配合康复新液纱条外敷对肛肠术后创面促愈作用的临床研究.pdf》由会员上传分享，免费在线阅读，更多相关内容在行业资料-天天文库。

1、中医药2013生月第32鲞筮期垦gJQ婴i塑一ChineseMedicine,，1y：至，Q：·331·半导体激光治疗仪局部照射配合康复新液纱条外敷对肛肠术后创面促愈作用的临床研究梅荣王秀燕t侯月芹武海霞t朱香如李杨肖新凯李绍旦。(1．解放军总医院中医院肛肠科，北京100853；2．解放军总医院中医院，北京100853)基金项目：军队中医药科研专项课题(10ZYZ241)通信作者：李绍旦，Tel：(010)66939635，E-mail：lsd301@126．corn【摘要】目的观察半导体激光治疗仪局部照射配合中药康复新液

2、纱条外敷对肛肠病术后创面愈合的影响。方法将240例肛肠病术后患者随机分为治疗组和对照组各120例。对照组术后第1天起常规换药后予以中药康复新液纱条外敷，治疗组则于术后第1天起以半导体激光治疗仪对术后创面进行局部照射，观察2组患者术后疼痛、水肿、创面愈合的情况。结果治疗组术后第3天基本无疼痛或轻度疼痛者113例(94．17％)，对照组为98例(81．67％)，2组比较差异有统计学意义(P

3、疗组术后创面愈合时间明显短于对照组，差异有统计学意义(P<0．05o结论半导体激光治疗仪局部照射配合中药康复新液纱条外敷可显著促进肛肠病术后创面愈合。【关键词】半导体激光治疗仪；康复新液；肛肠病术后；局部照射；外敷Clinicalstudyoflocalirradiationbysemiconductor]ssertherapeuticapparatuscombinedwithKangfuxtnsolutiongauzeexternalapplicationonrecoveryefectafteranorectaloper

4、ationMEIRong，WANGXiu-yan，HOUYue-qin，WUHai-xia，ZHUXiang-rn，LIYang，XIAOXin-kai，LIShac-dan(1．DepartmentofColoproctology，TraditionalChineseMedicdHospitalofPLAGeneralHospital，Beijing100853，China；2．TraditionalChineseMedicalHospitalofPLAGeneralHospital，Beijing100853)Abst

5、ractObjectiveToobservetherecoveryefectoflocalirradiationofsemiconductorlasertherapeuticappa胁scombinedwithKangfuxinsolutiongauzeexternalapplicationafteranorectaloperation．MethodsTwohundredandfortycasesofpostoperationonanorectaldiseaseswer℃randomlydividedintoatreatm

6、entgroupandacontrolgroup．120cagesineachone．ThecontrolgroupwastreatedbyKangfuxingauzeexternalapplicationbesidestheroutinedressingsincethe1stdayafteroperation，andonthebasistreatmentofthecontrolgroup，thetreatmentgroupWagtreatedbylocalirradiationofsemiconductorlaserth

7、erapeuticapparatus．Theconditionofpostoperativepain，swellingandwoundhealingWagobservedinbothgroups．ResultsTherewere113cages(94．17％)inthetreatmentgroupand98cages(81．67％)inthecontrolgroupwithlittleormildpainatthe3rddayafteroperation，andtherewassignificantdiferencebet

8、weenthetwogroups(P<0．05)；atthe7thdayafteroperation，theswellingaroundtheedgeofwoundsubsidedinthetreatmentgroupwith106csBes(88-33％)andinthecontrolgroupwit